Bio-Techne Corp (NASDAQ:TECH) has scheduled a conference call for 4th August 2020 at 9:00 AM Eastern Time to announce its 4Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.bio-techne.com
Earnings Expectation
Bio-Techne Corp is reporting fourth quarter financial results on Tuesday 4th August 2020, before market open.
According to analysts surveyed by Thomson Reuters, TECH is expected to report 4Q20 income of $ 0.75 per share from revenue of $ 163.91 million.
For the full year, analysts anticipate top line of $ 726.76 million, while looking forward to income of $ 4.29 per share bottom line.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide. It operates in three segments: Biotechnology, Protein Platforms, and Diagnostics. The Biotechnology segment offers specialized proteins, such as cytokines and growth factors, immunoassays, antibodies, and related reagents to the biotechnology research community; and in situ hybridization, media, and other cell culture products and reagents.
